JP2012102105A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012102105A5 JP2012102105A5 JP2011265649A JP2011265649A JP2012102105A5 JP 2012102105 A5 JP2012102105 A5 JP 2012102105A5 JP 2011265649 A JP2011265649 A JP 2011265649A JP 2011265649 A JP2011265649 A JP 2011265649A JP 2012102105 A5 JP2012102105 A5 JP 2012102105A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- antigen
- peptide according
- hla
- cytotoxic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 18
- 150000001413 amino acids Chemical class 0.000 claims 5
- 239000000427 antigen Substances 0.000 claims 5
- 102000036639 antigens Human genes 0.000 claims 5
- 108091007433 antigens Proteins 0.000 claims 5
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 5
- 230000001939 inductive effect Effects 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 230000033115 angiogenesis Effects 0.000 claims 4
- 210000000612 antigen-presenting cell Anatomy 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 210000001808 exosome Anatomy 0.000 claims 3
- 230000002163 immunogen Effects 0.000 claims 3
- 230000001404 mediated effect Effects 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- 229960005486 vaccine Drugs 0.000 claims 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 230000001900 immune effect Effects 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 claims 1
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 1
- 108010088729 HLA-A*02:01 antigen Proteins 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000009401 metastasis Effects 0.000 claims 1
- 229930182817 methionine Natural products 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65752705P | 2005-02-28 | 2005-02-28 | |
| US60/657,527 | 2005-02-28 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007529685A Division JP4931154B2 (ja) | 2005-02-28 | 2006-02-17 | 血管内皮増殖因子受容体１に由来するエピトープ・ペプチドおよびこれらのペプチドを含むワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012102105A JP2012102105A (ja) | 2012-05-31 |
| JP2012102105A5 true JP2012102105A5 (enExample) | 2013-02-28 |
| JP5789820B2 JP5789820B2 (ja) | 2015-10-07 |
Family
ID=36581423
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007529685A Expired - Fee Related JP4931154B2 (ja) | 2005-02-28 | 2006-02-17 | 血管内皮増殖因子受容体１に由来するエピトープ・ペプチドおよびこれらのペプチドを含むワクチン |
| JP2010129158A Expired - Lifetime JP4843095B2 (ja) | 2005-02-28 | 2010-06-04 | 血管内皮増殖因子受容体１に由来するエピトープ・ペプチドおよびこれらのペプチドを含むワクチン |
| JP2011265649A Expired - Fee Related JP5789820B2 (ja) | 2005-02-28 | 2011-12-05 | 血管内皮増殖因子受容体１に由来するエピトープ・ペプチドおよびこれらのペプチドを含むワクチン |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007529685A Expired - Fee Related JP4931154B2 (ja) | 2005-02-28 | 2006-02-17 | 血管内皮増殖因子受容体１に由来するエピトープ・ペプチドおよびこれらのペプチドを含むワクチン |
| JP2010129158A Expired - Lifetime JP4843095B2 (ja) | 2005-02-28 | 2010-06-04 | 血管内皮増殖因子受容体１に由来するエピトープ・ペプチドおよびこれらのペプチドを含むワクチン |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US7919099B2 (enExample) |
| EP (4) | EP1855707B1 (enExample) |
| JP (3) | JP4931154B2 (enExample) |
| CY (1) | CY1112867T1 (enExample) |
| DK (3) | DK2095822T3 (enExample) |
| ES (3) | ES2442294T3 (enExample) |
| PL (3) | PL1855707T3 (enExample) |
| PT (3) | PT2289533E (enExample) |
| SI (3) | SI2289533T1 (enExample) |
| WO (1) | WO2006093030A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2261249T3 (en) | 2002-09-12 | 2015-02-16 | Oncotherapy Science Inc | KDR peptides and vaccines comprising the same |
| PL2119447T3 (pl) * | 2007-02-16 | 2013-08-30 | Oncotherapy Science Inc | Terapia szczepionkowa przeciwko neowaskularyzacji naczyniówkowej |
| TW201109029A (en) * | 2009-06-11 | 2011-03-16 | Oncotherapy Science Inc | Vaccine therapy for choroidal neovascularization |
| US20150359864A1 (en) | 2012-03-09 | 2015-12-17 | Oncotherapy Science, Inc. | Pharmaceutical composition containing peptides |
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| KR20250057128A (ko) | 2015-12-30 | 2025-04-28 | 코디악 사이언시스 인코포레이티드 | 항체 및 이의 접합체 |
| JP7168228B2 (ja) * | 2017-05-19 | 2022-11-09 | 慶應義塾 | 脳神経疾患に対するペプチドワクチン及びペプチドワクチン組成物 |
| US12071476B2 (en) | 2018-03-02 | 2024-08-27 | Kodiak Sciences Inc. | IL-6 antibodies and fusion constructs and conjugates thereof |
| AU2020364071A1 (en) | 2019-10-10 | 2022-05-26 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| JPH0418667A (ja) * | 1989-07-05 | 1992-01-22 | Tohoku Nippon Denki Software Kk | 自動配送システム |
| JPH0350140A (ja) * | 1989-07-18 | 1991-03-04 | Seiko Epson Corp | 分布屈折率レンズの製造方法 |
| WO1994021679A1 (en) | 1993-03-25 | 1994-09-29 | Merck & Co., Inc. | Inhibitor of vascular endothelial cell growth factor |
| US5804566A (en) | 1993-08-26 | 1998-09-08 | The Regents Of The University Of California | Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
| US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
| US5736524A (en) | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
| US5922687A (en) | 1995-05-04 | 1999-07-13 | Board Of Trustees Of The Leland Stanford Junior University | Intracellular delivery of nucleic acids using pressure |
| CA2225553A1 (en) | 1995-08-03 | 1997-02-20 | Rijksuniversiteit Te Leiden | Cell derived antigen presenting vesicles |
| US5853719A (en) | 1996-04-30 | 1998-12-29 | Duke University | Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| US6100071A (en) | 1996-05-07 | 2000-08-08 | Genentech, Inc. | Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production |
| WO1998004720A1 (en) | 1996-07-26 | 1998-02-05 | Sloan-Kettering Institute For Cancer Research | Method and reagents for genetic immunization |
| FR2766205B1 (fr) | 1997-07-16 | 2002-08-30 | Inst Nat Sante Rech Med | Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede |
| US6200954B1 (en) * | 1998-09-04 | 2001-03-13 | National University Of Singapore | Small peptides having potent anti-angiogenic activity |
| WO2002072627A2 (en) * | 2001-03-09 | 2002-09-19 | Callistogen Ag | Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination |
| FI110549B (fi) | 2001-06-29 | 2003-02-14 | Nokia Corp | Menetelmä ja järjestely liikkeen määrittämiseksi |
| US20030157101A1 (en) * | 2001-11-15 | 2003-08-21 | Carlo Gambacorti-Passerini | Immunogenic ALK peptides |
| JP4035845B2 (ja) | 2001-12-10 | 2008-01-23 | 株式会社グリーンペプタイド | 腫瘍抗原 |
| CU23178A1 (es) * | 2002-04-15 | 2006-09-22 | Ct Ingenieria Genetica Biotech | INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA |
| JP2004018667A (ja) | 2002-06-17 | 2004-01-22 | National Institute Of Advanced Industrial & Technology | 高分子化合物膜の表面における炭酸カルシウム被膜の製造方法 |
| AU2003254950A1 (en) | 2002-08-26 | 2004-03-11 | Kirin Beer Kabushiki Kaisha | Peptides and drugs containing the same |
| DK2261249T3 (en) | 2002-09-12 | 2015-02-16 | Oncotherapy Science Inc | KDR peptides and vaccines comprising the same |
| TW201109029A (en) | 2009-06-11 | 2011-03-16 | Oncotherapy Science Inc | Vaccine therapy for choroidal neovascularization |
-
2006
- 2006-02-17 EP EP06714491A patent/EP1855707B1/en not_active Expired - Lifetime
- 2006-02-17 PT PT101779601T patent/PT2289533E/pt unknown
- 2006-02-17 ES ES09007549.0T patent/ES2442294T3/es not_active Expired - Lifetime
- 2006-02-17 DK DK09007549.0T patent/DK2095822T3/da active
- 2006-02-17 PL PL06714491T patent/PL1855707T3/pl unknown
- 2006-02-17 ES ES06714491T patent/ES2385396T3/es not_active Expired - Lifetime
- 2006-02-17 PL PL10177960T patent/PL2289533T3/pl unknown
- 2006-02-17 DK DK10177960.1T patent/DK2289533T3/da active
- 2006-02-17 SI SI200631668T patent/SI2289533T1/sl unknown
- 2006-02-17 EP EP10177956A patent/EP2289532A1/en not_active Withdrawn
- 2006-02-17 PT PT90075490T patent/PT2095822E/pt unknown
- 2006-02-17 ES ES10177960T patent/ES2435650T3/es not_active Expired - Lifetime
- 2006-02-17 SI SI200631689T patent/SI2095822T1/sl unknown
- 2006-02-17 WO PCT/JP2006/303352 patent/WO2006093030A1/en not_active Ceased
- 2006-02-17 EP EP09007549.0A patent/EP2095822B1/en not_active Expired - Lifetime
- 2006-02-17 DK DK06714491.5T patent/DK1855707T3/da active
- 2006-02-17 US US11/816,893 patent/US7919099B2/en active Active
- 2006-02-17 JP JP2007529685A patent/JP4931154B2/ja not_active Expired - Fee Related
- 2006-02-17 EP EP10177960.1A patent/EP2289533B1/en not_active Expired - Lifetime
- 2006-02-17 PT PT06714491T patent/PT1855707E/pt unknown
- 2006-02-17 PL PL09007549T patent/PL2095822T3/pl unknown
- 2006-02-17 SI SI200631350T patent/SI1855707T1/sl unknown
-
2010
- 2010-06-04 JP JP2010129158A patent/JP4843095B2/ja not_active Expired - Lifetime
-
2011
- 2011-03-03 US US13/040,177 patent/US8257711B2/en not_active Expired - Fee Related
- 2011-12-05 JP JP2011265649A patent/JP5789820B2/ja not_active Expired - Fee Related
-
2012
- 2012-06-12 CY CY20121100533T patent/CY1112867T1/el unknown
- 2012-08-03 US US13/566,933 patent/US8663647B2/en not_active Expired - Fee Related
-
2014
- 2014-01-21 US US14/160,436 patent/US20140186381A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012176978A5 (enExample) | ||
| JP2010500399A5 (enExample) | ||
| MX340014B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX2012008998A (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX342291B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX340016B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| JP2014534202A5 (enExample) | ||
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| RU2011110504A (ru) | Эпитопные пептиды inhbb и вакцины, содержащие данные пептиды | |
| AR107020A2 (es) | Vacuna de pcsk9 (proteína convertasa subtilisina-kexina tipo 9) | |
| JP2015214545A5 (enExample) | ||
| JP2016502551A5 (enExample) | ||
| JP2012500001A5 (enExample) | ||
| ES2673556T3 (es) | Vacunas para el VHS-2 | |
| JP2015517488A5 (enExample) | ||
| JP2013507907A5 (enExample) | ||
| SV2016005145A (es) | Polipéptidos cíclicos para el tratamiento de la insuficiencia cardiaca | |
| IN2014KN01716A (enExample) | ||
| JP2019531293A5 (enExample) | ||
| JP2008530975A5 (enExample) | ||
| JP2015533791A5 (enExample) | ||
| JP2012529293A5 (enExample) | ||
| JP2014139185A5 (enExample) | ||
| RU2015112625A (ru) | Пептид, применение пептида для лечения сердечно-сосудистых заболеваний, нуклеотидная последовательность, вектор экспрессии, хозяйская клетка, фармацевтическая композиция | |
| JP2016513471A5 (enExample) |